UGT1A9 Substrates with a Narrow Therapeutic Index
- Name
- UGT1A9 Substrates with a Narrow Therapeutic Index
- Accession Number
- DBCAT004544
- Description
Not Available
- Drugs
Drug Drug Description Mycophenolic acid An immunosuppressant used to prevent organ transplant rejections. Valproic acid An anticonvulsant used to control complex partial seizures and both simple and complex absence seizures. Enasidenib An isocitrate dehydrogenase-2 inhibitor used to treat relapsed or refractory acute myeloid leukemia with an isocitrate dehydrogenase-2 mutation. Sorafenib A kinase inhibitor used to treat unresectable liver carcinoma, advanced renal carcinoma, and differentiated thyroid carcinoma. Irinotecan An antineoplastic enzyme inhibitor used to treat metastatic carcinoma of the colon or rectum. Regorafenib A kinase inhibitor used to treat patients with metastatic colorectal cancer, unresectable, locally advanced, or metastatic gastrointestinal stromal tumors, and hepatocellular carcinoma. Phenytoin An anticonvulsant drug used in the prophylaxis and control of various types of seizures. - Drugs & Drug Targets